Free Trial
NASDAQ:SNOA

Sonoma Pharmaceuticals (SNOA) Stock Price, News & Analysis

Sonoma Pharmaceuticals logo
$4.45 -0.11 (-2.41%)
Closing price 04:00 PM Eastern
Extended Trading
$4.42 -0.03 (-0.56%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Sonoma Pharmaceuticals Stock (NASDAQ:SNOA)

Key Stats

Today's Range
$4.39
$4.60
50-Day Range
$2.85
$5.35
52-Week Range
$1.75
$6.92
Volume
40,453 shs
Average Volume
3.90 million shs
Market Capitalization
$7.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SNOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNOA Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
Sonoma Pharmaceuticals expands into UK market
See More Headlines

SNOA Stock Analysis - Frequently Asked Questions

Sonoma Pharmaceuticals' stock was trading at $2.69 at the start of the year. Since then, SNOA shares have increased by 65.4% and is now trading at $4.45.

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) posted its quarterly earnings data on Thursday, August, 7th. The company reported ($0.37) EPS for the quarter, beating analysts' consensus estimates of ($0.51) by $0.14. The business had revenue of $4.01 million for the quarter, compared to analysts' expectations of $4.26 million. Sonoma Pharmaceuticals had a negative net margin of 23.87% and a negative trailing twelve-month return on equity of 50.00%.

Top institutional shareholders of Sonoma Pharmaceuticals include Heron Bay Capital Management (2.06%).
View institutional ownership trends
.

Shares of SNOA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sonoma Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Meta Platforms (META), NVIDIA (NVDA), Bristol Myers Squibb (BMY), Advanced Micro Devices (AMD), Ford Motor (F) and PayPal (PYPL).

Company Calendar

Last Earnings
8/07/2025
Today
8/29/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SNOA
CIK
1367083
Employees
180
Year Founded
1999

Profitability

EPS (Trailing Twelve Months)
($2.46)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.46 million
Net Margins
-23.87%
Pretax Margin
-21.14%
Return on Equity
-50.00%
Return on Assets
-16.79%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.70
Quick Ratio
1.92

Sales & Book Value

Annual Sales
$14.29 million
Price / Sales
0.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.47 per share
Price / Book
1.80

Miscellaneous

Outstanding Shares
1,640,000
Free Float
1,239,000
Market Cap
$7.30 million
Optionable
Not Optionable
Beta
1.25

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:SNOA) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners